NAGE Niagen Bioscience, Inc.

NASDAQ
$2.11

Niagen Bioscience, Inc. (NAGE) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is a loss of $0.04 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -9.3% since its last earnings release on November 4, 2026.

Niagen Bioscience, Inc. Reported In-line with Estimates
Wednesday, November 4, 2026 · 4:02 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 3
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs ($0.04)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.11

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Niagen Bioscience, Inc.

Niagen Bioscience, Inc. is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.